Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Vincent I. Ahonkhai"'
Autor:
Aima A, Ahonkhai, Olumuyiwa O, Odusanya, François P, Meurice, Leslie J, Pierce, Temitope O, Durojaiye, Ewan F, Alufohai, Ralph, Clemens, Vincent I, Ahonkhai
Publikováno v:
Ahonkhai, A A, Odusanya, O O, Meurice, F P, Pierce, L J, Durojaiye, T O, Alufohai, E F, Clemens, R & Ahonkhai, V I 2022, ' Lessons for strengthening childhood immunization in low-and middle-income countries from a successful public-private partnership in rural Nigeria ', International health, vol. 14, no. 6, pp. 632-638 . https://doi.org/10.1093/inthealth/ihab089
Background Immunization is a cost-effective public health strategy to reduce vaccine preventable disease, especially in childhood. Methods This paper reports the philosophy, service delivery, achievements and lessons learned from an immunization prog
Autor:
Jim Todd, Joan M. Staub, Leslie C. Jonas, P. P. Vella, A.M. Greenwood, Vincent I. Ahonkhai, Mulholland Ek, Linda J. Lukacs, Brian Greenwood, ChrisAnna M. Mink
Publikováno v:
The Pediatric Infectious Disease Journal. 12:632-637
To ensure compliance and to reduce costs it is important, especially in less developed countries, that programs of child immunization should require as few clinic attendances and as few injections as possible. Therefore we have investigated whether a
Autor:
Vincent I. Ahonkhai, Janne Hill, Mathuram Santosham, Raymond Reid, Linda J. Lukacs, Mark Wolff
Publikováno v:
The Pediatric Infectious Disease Journal. 10:113-116
The safety and immunogenicity of a Haemophilus influenzae type b polysaccharide conjugate vaccine linked to the outer membrane protein complex of Neisseria meningitidis (Hib-OMP) were evaluated among Apache and Navajo infants and children. One dose o
Publikováno v:
Pediatrics. 86:102-107
Recent studies in the United States and Europe have shown that Haemophilus influenzae type b polysaccharide-protein conjugate vaccines can induce protective antibody levels in young infants, but it was not clear that this would be the case in African
Autor:
Vincent I. Ahonkhai, Linda J. Lukacs, Leslie C. Jonas, Holly Matthews, Philip P. Vella, Ronald W. Ellis, Joan M. Staub, Kathleen T. Dolan, Cynthia M. Rusk, Gary B. Calandra, Robert J. Gerety
Publikováno v:
Pediatrics. 85:676-681
Although systemic infections caused by Haemophilus influenzae type b occur worldwide, detailed epidemiologic data are available in but a few countries.1-3 The public health impact of morbidity, mortality, and serious sequelae from disease caused by H
Autor:
Joan M. Staub, Vincent I. Ahonkhai, Timothy L. Schofield, Philip P. Vella, Kathleen T. Dolan, Ronald W. Ellis
Publikováno v:
Journal of immunoassay. 12(4)
An enzyme-linked immunosorbent assay (ELISA) has been developed and validated to quantitate IgG1 and IgG2 antibody to polyribosyl-ribitol phosphate (PRP), the capsular polysaccharide of Haemophilus influenzae type b (Hib). The sera of children and in
Publikováno v:
The Pediatric Infectious Disease Journal. 8:740-744
Imipenem-cilastatin was evaluated for tolerability and efficacy in a multicenter open, noncomparative trial involving 178 infants and children with bacterial infections. Imipenemcilastatin was administered in total daily dosages of 100 mg/kg for pati
Publikováno v:
Journal of Antimicrobial Chemotherapy. 16:549-554
Imipenem, along with ampicillin, chloramphenicol, ceftazidime, aztreonam and ceftriaxone were tested against 100 clinical isolates of Haemophilus influenzae. Eighty-eight of the isolates were serotype b, 35 isolates were beta-lactamase producers, and
Autor:
Evan Charney, Gerald M. Fendrick, Martin T. Stein, Robert H. Pantell, Ronald J. Sweren, David A. Bergman, Molly P. Coulter, Michael R. Lawless, Kenneth B. Roberts, Barry S. Lachman, Vincent I. Ahonkhai
Publikováno v:
The Journal of pediatrics. 103(6)
Nine centers collaborated to determine the rate of urinary tract infection in infants with unexplained fever, to determine whether the rate is higher in febrile infants than in asymptomatic infants, and whether the yield justifies urine cultures in f
Publikováno v:
Antimicrobial agents and chemotherapy. 22(4)
The in vitro activity of cefodizime (HR-221), a new cephalosporin antibiotic, was compared with the activities of selected antimicrobial agents against a broad spectrum of aerobic bacteria. Cefodizime concentrations of 2 micrograms/ml inhibited about